Lentinan Combined with (125)I Brachytherapy for Recurrent Ovarian Cancer

Objective. To investigate the clinical value of lentinan combined with (125)I brachytherapy in the treatment of recurrent ovarian cancer. Methods. A total of 160 patients with recurrent ovarian cancer admitted at Jiaozhou Central Hospital from June 2009 to October 2015 were enrolled in this study an...

Full description

Saved in:
Bibliographic Details
Main Authors: Qin Jiang, Shuai Pang, Yifang Xia, Hongmei Sun, Yingying Yu
Format: article
Language:EN
Published: Hindawi Limited 2021
Subjects:
Online Access:https://doaj.org/article/3ec21415ad0f426cafe3ae2c482a54b5
Tags: Add Tag
No Tags, Be the first to tag this record!